Gene: SYNE2
Official Full Name: spectrin repeat containing nuclear envelope protein 2provided by HGNC
Gene Summary: The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05406 | SYNE2 Knockout cell line (HeLa) | Human | SYNE2 | 1:3~1:6 | Negative | Online Inquiry |
KO05407 | SYNE2 Knockout cell line (HCT 116) | Human | SYNE2 | 1:2~1:4 | Negative | Online Inquiry |
KO05408 | SYNE2 Knockout cell line (HEK293) | Human | SYNE2 | 1:3~1:6 | Negative | Online Inquiry |
KO05409 | SYNE2 Knockout cell line (A549) | Human | SYNE2 | 1:3~1:4 | Negative | Online Inquiry |
SYNE2 Gene Knockout Cell Lines are a cutting-edge biological tool designed to facilitate the study and analysis of the SYNE2 gene, which is pivotal in maintaining the structure of the nuclear envelope and facilitating cellular organization. By employing a targeted CRISPR-Cas9 gene-editing technique, these cell lines allow researchers to genetically modify and knock out the SYNE2 gene, providing a unique platform to elucidate its functions and consequences on cellular processes.
The primary mechanism of action involves the precise disruption of the SYNE2 gene sequence, leading to the production of knockout cells that exhibit a lack of SYNE2 protein expression. This knockout model is indispensable for investigating the gene’s role in various cellular activities, such as mechanotransduction, cell shape, and transport processes within the cell nucleus. Researchers can observe phenotypic changes and assess the impact of SYNE2 loss on cellular health, proliferation, and signaling pathways.
The scientific importance of SYNE2 Gene Knockout Cell Lines extends into developmental biology, neurobiology, and oncology, providing a platform for translational research aimed at understanding diseases associated with nuclear envelope defects, such as muscular dystrophies and certain cancers. In clinical settings, these models can aid in identifying potential therapeutic targets and developing strategies for drug discovery.
What sets SYNE2 Gene Knockout Cell Lines apart from conventional genetic models is the high specificity and efficiency of the CRISPR-Cas9 application, resulting in consistent and reproducible knockout efficiencies. Furthermore, these cell lines come with validated phenotypic characterization, saving researchers valuable time in experimental design.
For researchers and clinicians focused on dissecting genetic roles or developing targeted therapies, SYNE2 Gene Knockout Cell Lines represent an invaluable asset in unlocking the complexities of human health and disease. Our company brings expertise in genetic engineering and cell line development, ensuring that we provide high-quality biological products to empower scientific advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.